Medical Science Liaison, Oncology - Lung & GU Tumors North Texas

Medical Science Liaison, Oncology - Lung & GU Tumors

The primary role of the Medical Science Liaison (MSL) is to engage in meaningful peer-to-peer scientific dialogue with healthcare system leaders such as Regional Thought Leaders (RTLs), National Thought Leaders, and Healthcare Professional (HCPs) within a defined geography to translate science into patient care. MSLs will also engage the top HCPs in high-disease burden hospitals.

The MSL captures medical insights and acts as a clinical & scientific advisor to cross-functional partners. Ensures applicable interactions are aligned with enterprise and medical strategies and ultimately serve to ensure patients have access to BMS medicines through their efforts to ensure the medical community is fully apprised of their safe and effective use. Additionally, the MSL will work with medical community to address other pertinent scientific related questions not limited to approved assets and indications.

MSL engagement with HCPs is focused on pre- and peri-launch activities or according to lifecycle needs of the brand. The MSL will also engage in educational dialogue with relevant HCPs and share relevant clinical evidence and information based on the physicians' needs and in accordance with the field medical plan.

This role is field-based, and it is anticipated that the employee will spend a majority of the time in the field interacting with external stakeholders, including investigators and clinical thought leaders, while also supporting internal stakeholders and continuing to maintain a high level of therapeutic expertise.

Key Responsibilities

• Develops trusted relationships with appropriate academic and community Thought Leaders (TLs) in Oncology through high-quality peer-to-peer scientific dialogue in both proactive and reactive settings. The MSL will use various channels for interactions (1:1, group presentations, virtual, etc.)
• Effectively collaborates and engages in scientific dialogue with TLs to gain insights on clinical landscape to ensure development of a medical plan that is both product/disease area focused and translates into effective launch
• Proactively engages in scientific and clinical conversation to ensure development of a medical plan that is both product/disease area focused and translates into effective launch and LCM activities.
• Engages with medical societies, PAGs (Patient Advocacy Groups) and guideline committee members as appropriate.
• Provides training for external speakers as needed.
• Strategically engages payers in the pre- and peri-launch phases (with fHEOR and Account Executives).
• Provides medical support to address unsolicited HCP questions in real-time, both in face-to-face interactions and through the Medical on Call virtual capability.
• Develops credible connections with key Thought Leaders (TLs) in oncology through high-quality peer-to-peer scientific dialogue.
• Appropriately document and achieve annual goals
• Leverages digital capabilities to enhance medical engagement

Clinical Trial engagement

• Provides recommendations and insights to clinical development team on study feasibilities within the therapeutic area based on knowledge of the field and through direct contacts with potential investigators, as agreed with home office medical and GDO.
• Liaises with key large accounts to understand clinical barriers to patient access and ensuring equity in access to clinical trials.
• Leads major evidence read-outs with clinical trial investigators e.g., Ph 3 top-line data.
• Support Interventional and Non-Interventional Research (NIR) studies (e.g. identification and assessment of potential study sites) to facilitate patient recruitment and/or discussions around the safe and effective use of BMS investigational products, as agreed with home office medical and GDO and as defined by the study scope document
• Provide recommendations and insights to clinical development team on study and site feasibilities within the therapeutic area based on knowledge of the field and through direct contacts with potential investigators, as agreed with home office medical and GDO
• Support HCPs in the ISR submission and execution process and study follow-up as agreed upon with home office medical and GDO
• Ensure that BMS Pharmacovigilance procedural documents are understood and applied by investigators of local studies, and alert appropriate BMS personnel to any identified Adverse Events
• If applicable, support CRO sponsored studies as agreed with home office medical and GDO and as defined by the study scope document

Required Qualifications & Experience

• MD, PharmD, PhD, APP, PA, NP with experience in a specific Disease Area or with a broad medical background or relevant pharmaceutical experience
• Working in a scientific and/or clinical research environment. Field medical expertise preferred.
• Deep understanding of TL environment and needs.

Strong oncology experience required

• Scientific or clinical disease area knowledge, patient treatment trends, clinical landscape
• Pharmaceutical industry including…